Technological Outcomes(Published Articles) 2018-12-19T10:27:06+00:00

Technological Outcomes

Date of publication Name of journal Title of article Link to original article
18-Sep-17 PLoS ONE 12(9): e0185074 Role of the P2 residue of human alpha 1- antitrypsin in determining target protease specificity https://www.ncbi.nlm.nih.gov/pubmed/28922398
15-Jul-16 PLoS ONE 11(7): e0159451 Oxidation Protection in Metal-Binding Peptide Motif and Its Application to Antibody for Site-Selective Conjugation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946781/
07-Mar-16 Glycoconj J (2016) 33:201–208 Additional N-glycosylation in the N-terminal region of recombinant human alpha-1 antitrypsin enhances the circulatory half-life in Sprague-Dawley rats https://www.ncbi.nlm.nih.gov/pubmed/26947874
27-May-13 BMB Rep. 2013; 46(12): 606-610 Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133866/
12-Oct-12 Glycoconj J (2013) 30:537–547 N-glycan analysis of human α1-antitrypsin produced in Chinese hamster ovary cells https://www.ncbi.nlm.nih.gov/pubmed/23065139
27-May-11 Regulatory Peptides 2011; 170: 1–3 The N-terminal alanine-extended GLP-1/IgG-Fc fusion protein confers resistance to DPP-IV and reduces serum glucose level in db/db mice https://www.ncbi.nlm.nih.gov/pubmed/21621561
28-Aug-09 Bull. Korean Chem. Soc. 2009; 30(10): 2471-2474 Novel DPP-IV-resistant Analogs of GLP-1: The N-terminal Extension of GLP-1 by a Single Amino Acid https://www.researchgate.net/publication/281909251